[Lecture Report] The 7th NIKKEI FT Communicable Diseases Conference – Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation- (The NIKKEI, November 6-7, 2020, Yokohama City, Kanagawa Prefecture)
date : 11/27/2020
On November 6 and 7, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 7th NIKKEI FT Communicable Diseases Conference, which was entitled “Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation.” The event was co-hosted by the NIKKEI and the Financial Times.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.
Friday, November 6, 2020
Lunch Session- BD Japan: The role of testing in communicable diseases~Learning from COVID-19
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-1: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-2: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Saturday, November 7, 2020
Keynote Session- Dr. Yasuhiro Suzuki, Former Vice-Minister for Health/Chief Medical & Global Health Officer, MHLW, Japan
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Agenda6- Coexisting with COVID-19 ~The Role of Japanese Initiatives
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Summary Session
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Conclusion/Statement
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
Featured Posts
-
2025-11-13
[Registration Open] (Webinar) The 1st J-PEP Seminar – Initiating Policy Advocacy from Meaningful Involvement (December 8, 2025)
-
2025-12-01
[Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)







